Stock Market & Financial News

Loading...
USD/CHF Price Forecast: Bulls eye 0.8200 as RSI turns higher

USD/CHF Price Forecast: Bulls eye 0.8200 as RSI turns higher

USD/CHF Price Forecast: Bulls eye 0.8200 as RSI turns higher

USDC
USDCHF
Fxstreet | 1 week ago

Arbitrum Posts $6.2M in H1 Income as Robinhood Chain Fuels New Revenue Growth

Arbitrum DAO generated $6.19 million in first-half 2026 income from transaction fees, Timeboost, Expansion Program licensing and treasury management, with gross margins above 97%. Robinhood Chain produced $360,000 in July licensing fees, representing 35% of Arbitrum DAO's income, with third-quarter income tracking more than 40% above Q2. Robinhood Chain hit $3.

ARBUSD
Crypto-economy | 1 week ago

Microsoft to start disclosing Azure quarterly revenue as company consolidates business units

Microsoft will begin reporting Azure revenue in dollars for the first time, providing more clarity about its business that competes with Amazon Web Services. The company is trimming the number of internal operating segments from three to two.

Microsoft Corp. logo MSFT
Cnbc | 1 week ago

Google Escapes Forced Breakup of AdX Marketplace

Google avoided a forced breakup of its advertising technology business, Reuters reported Wednesday (Sept. 2). U.S.

Alphabet Inc logo GOOG
Pymnts | 1 week ago
Bitcoin adoption highest in El Salvador and Venezuela, Cornell report finds

Bitcoin adoption highest in El Salvador and Venezuela, Cornell report finds

Cornell University has found that Bitcoin ownership is highest in El Salvador, Venezuela, and Nigeria after surveying 25,880 people across 25 countries.

BTCUSD
Crypto | 1 week ago
Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study Transcript

Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study Transcript

Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study Transcript

Teva Pharmaceutical Industries Ltd. ADR logo TEVA
Seekingalpha | 1 week ago
Uber says it is laying off 'about 10%' of its workforce worldwide

Uber says it is laying off 'about 10%' of its workforce worldwide

Ride-hailing giant Uber will lay off about 10% of its staff as part of "significant organizational changes," CEO Dara Khosrowshahi said in a message to employees released Wednesday.

Uber Technologies, Inc. logo UBER
Techxplore | 1 week ago
HPE follows in Dell's footsteps as it rides the AI server boom to a big earnings beat

HPE follows in Dell's footsteps as it rides the AI server boom to a big earnings beat

Unlike Dell, however, HPE focuses on enterprise and sovereign customers, which an analyst says have a better profit profile.

Hewlett Packard Enterprise Company logo HPE
Marketwatch | 1 week ago
Solana processed 5.2 billion transactions after revenue collapsed 87% – here's what changed

Solana processed 5.2 billion transactions after revenue collapsed 87% – here's what changed

August activity reached a new high after the memecoin fee boom that inflated revenue a year earlier had faded.

SOLUSD
Cryptoslate | 1 week ago
Snowflake's stock soars as the company blows away estimates with its AI-fueled forecast

Snowflake's stock soars as the company blows away estimates with its AI-fueled forecast

Companies looking to build AI tools on top of their data are turning to Snowflake, driving robust revenue growth.

Snowflake Inc. logo SNOW
Marketwatch | 1 week ago

Wintermute: Capital Rolls Into XRP As Alts Edge BTC Out

The big-time market maker just published their deep-dive into the market, smelling the altcoin season coming.

XRPUSD
Dailycoin | 1 week ago

Bayer Crop Science Targets €3B Cash Flow by 2029 With Seeds-Led Growth

Bayer Aktiengesellschaft ETR: BAYN outlined progress on its Crop Science division's five-year framework at a 2026 innovation event in Iowa, reaffirming targets for above-market sales growth, a mid-20s clean EBITDA margin and more than €3 billion in free operating cash flow by 2029.

Bayer AG Sponsored ADR logo BAYRY
Marketbeat | 1 week ago

NVIDIA & 4 Stocks Beyond Pure Plays to Gain From Quantum Boom in 2026

NVIDIA and four tech giants offer quantum exposure through cloud, software and infrastructure, helping investors tap the boom beyond pure plays.

NVIDIA Corporation logo NVDA
Zacks | 1 week ago

Buy Palo Alto Networks Stock? Earnings Reveal a $9.1B AI Security Boom

Palo Alto Networks' surging NGS ARR, strong cash flow and attractive valuation strengthen the case for PANW stock.

Palo Alto Networks, Inc. logo PANW
Zacks | 1 week ago

Filecoin price jumps 14% – Why FIL's rally still hinges on $0.86

Filecoin has rallied nearly 20% from Monday's open, and appeared ready to challenge the bearish swing structure.

FILUSD
Ambcrypto | 1 week ago

Judge refuses to block Arkansas news reporting on Google data center energy documents

An Arkansas federal judge denied a request by an energy company to temporarily block the Arkansas Democrat-Gazette from publishing additional details from confidential documents that the newspaper obtained about the company's involvement in building a facility that will supply power to a $4 billion Google data center in that state, a court filing showed. The company, Entergy Arkansas, also had asked Judge Lee Rudofsky to order that the Democrat-Gazette remove from its website information an article published on Monday about the documents.

Alphabet Inc logo GOOG
Cnbc | 1 week ago

Can AMD's Saudi AI Buildout Challenge NVIDIA and Broadcom?

AMD is scaling its Saudi AI push with HUMAIN, targeting 250 MW from 2027 and up to 1 GW by 2030 as it challenges NVIDIA and Broadcom.

Advanced Micro Devices, Inc. logo AMD
Zacks | 1 week ago

Bitcoin bull market remains unconfirmed, Nansen says

Bitcoin has gained roughly 22% over the past month, but Nansen analyst Nicolai Søndergaard has warned that weak spot flows, divided whale positions, and ETF withdrawals have yet to confirm a new bull market.

BTCUSD
Crypto | 1 week ago

AMD: Winning The Next Phase Of The AI Supercycle

Advanced Micro Devices, Inc. is rated Bullish, leveraging Helios rack-scale systems and acquisitions to lead agentic AI inference and challenge Nvidia's CUDA moat. Multi-gigawatt hyperscaler contracts and a 30% tokens-per-dollar cost advantage underpin long-term EPS growth and margin expansion for AMD. Key risks include potential U.S. bans on Chinese optical transceivers, which could disrupt Helios rack deployments and compress AMD's high forward valuation.

Advanced Micro Devices, Inc. logo AMD
Seekingalpha | 1 week ago

Gold rises as speculation of Yen intervention weighs on the US Dollar

Gold rises as speculation of Yen intervention weighs on the US Dollar

XAUU
XAUUSD
Fxstreet | 1 week ago

Belite Bio, Inc (BLTE) Discusses Prelaunch Strategy and Commercial Opportunity for Tinlarebant in Stargardt Disease Type 1 Transcript

Belite Bio, Inc (BLTE) Discusses Prelaunch Strategy and Commercial Opportunity for Tinlarebant in Stargardt Disease Type 1 Transcript

Belite Bio, Inc. logo BLTE
Seekingalpha | 1 week ago

MLPI: The Midstream Income Strategy Attracts Me

The NEOS MLP & Energy Infrastructure High Income ETF offers an actively managed, high-yield play on midstream and energy infrastructure with a covered-call overlay. MLPI's covered-call strategy is well-suited for a market where most midstream gains are realized, prioritizing monthly income over equity upside. With a TTM yield near 11% and a forward distribution rate of 14.75%, MLPI appeals to income-focused investors, especially those near or in retirement.

NEOS MLP & Energy Infrastructure High Income ETF logo MLPI
Seekingalpha | 1 week ago

Planet Labs Stock Tests Key Support Before Earnings

Planet Labs PBC (NYSE:PL) is set to report second-quarter earnings after the close tomorrow, Sept.

PLANET LABS PBC logo PL
Schaeffersresearch | 1 week ago

Can CYTK's Aficamten Strengthen Its HCM Growth Prospects?

Cytokinetics' aficamten shows added benefits in HCM studies, strengthening its potential in non-obstructive and obstructive disease.

Cytokinetics, Incorporated logo CYTK
Zacks | 1 week ago

Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies

Novartis' remibrutinib delivers positive phase III RMS results, reducing relapse rates versus Aubagio and supporting plans for global regulatory approvals.

Novartis AG Sponsored ADR logo NVS
Zacks | 1 week ago

HIMS Raises 2026 Revenue Outlook as Q2 Sales Rise 38.2% Despite Loss

HIMS raised its 2026 revenue outlook after Q2 sales jumped 38.2%, but margin contraction and an $86.3 million net loss highlighted growth costs.

Hims & Hers Health, Inc. logo HIMS
Zacks | 1 week ago

Reasons to Retain Hims & Hers Stock in Your Portfolio for Now

HIMS has entered the second half of 2026 with weight-loss, international and AI momentum, but margin pressure and FDA uncertainty remain.

Hims & Hers Health, Inc. logo HIMS
Zacks | 1 week ago

Why Palantir's stock is suffering its worst slump since February

After a strong postearnings rally in August, Palantir's rich valuation multiple is under pressure once again.

Palantir Technologies Inc. logo PLTR
Marketwatch | 1 week ago

DELL Q2 Earnings Beat Estimates, Strong AI Demand Aids Revenue Growth

Dell's Q2 fiscal 2027 results beat estimates as AI server demand surges, ISG revenues hit a record and management raises its full-year outlook.

Dell Technologies Inc. logo DELL
Zacks | 1 week ago

Delivery Hero board backs Uber's $15B takeover bid

Delivery Hero's board has signed off on Uber's $15 billion takeover offer and recommended shareholders approve the deal, which would create one the largest on-demand food delivery platforms in the world.

Hero Technologies Inc. logo HENC
Techcrunch | 1 week ago
Load More
Loading...